Stock Price
2.16
Daily Change
-0.03 -1.37%
Monthly
-51.89%
Yearly
-22.86%
Q2 Forecast
2.29

Acasti Pharma reported $1.24M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acasti Pharma USD 1.24M 1.08M Sep/2025
Addus HomeCare USD 149.48M 12K Mar/2026
Amarin USD 179.64M 14.82M Mar/2026
Cassava Sciences USD 40.11M 3.72M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Option Care Health USD 729.74M 99.6M Mar/2026
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Tilray USD 259.32M 8.32M Sep/2025